Age and high-dose methotrexate are associated to clinical acute encephalopathy in FRALLE 93 trial for acute lymphoblastic leukemia in children
Authors:
Open Access
- 14 December 2006
- journal article
- research article
- Published by Springer Nature in Leukemia
- Vol. 21 (2) , 238-247
Abstract
The objective of the study was to assess acute neurotoxicity associated with triple intrathecal therapy (TIT)±high-dose methotrexate (HD MTX) in children with acute lymphoblastic leukemia (ALL). 1395 children were enrolled on FRALLE 93 protocol from 1993 to 1999. Lower-risk group (LR, n=182) were randomized to weekly low-dose MTX at 25 mg/m2/week (LD MTX, n=81) or HD MTX at 1.5 g/m2/2 weeks × 6 (n=77). Intermediate-risk group (IR, n=672) were randomized to LD MTX (n=290) or HD MTX at 8 g/m2/2 weeks × 4 (n=316). Higher-risk group (HR, n=541) prednisone-responder patients received LD MTX and cranial radiotherapy. HR group steroid resistant cases were grafted (autologous or allogenic). TIT (MTX, cytarabine and methylprednisolone) was given every 2 weeks during 16–18 weeks and every 3 months during maintenance therapy in LR and IR patients. 52 patients (3.7%) developed neurotoxicity. Isolated seizures: n=15 (1.1%), peripheral and spinal neuropathy: n=17 (1.2%) and encephalopathy: n=20 (1.4%). Age >10 years was significantly associated with neurotoxicity (P=0.01) and use of HD MTX is associated with encephalopathy (P=0.03). Sequels are reported respectively in 60 and 33% of spinal neuropathy and encephalopathy cases. Current strategies tailoring risk of neurological sequels has to be defined.Keywords
This publication has 44 references indexed in Scilit:
- Intrathecal triple therapy decreases central nervous system relapse but fails to improve event-free survival when compared with intrathecal methotrexate: results of the Children's Cancer Group (CCG) 1952 study for standard-risk acute lymphoblastic leukemia, reported by the Children's Oncology GroupBlood, 2006
- The Prognosis and Survival of Childhood Acute Lymphoblastic Leukemia with Central Nervous System RelapsePediatric Hematology and Oncology, 2004
- New insights into paediatric haemostasis: thrombosis and bleeding issuesThrombosis and Haemostasis, 2004
- Childhood acute lymphoblastic leukemiaReviews in Clinical and Experimental Hematology, 2002
- Intrathecal Chemotherapy-Related Myeloencephalopathy in a Young Child with Acute Lymphoblastic LeukemiaPediatric Hematology and Oncology, 1995
- Acute ascending myelitis and encephalopathy after intrathecal cytosine arabinoside and methotrexate in an adolescent boy with acute lymphoblastic leukemiaBrain and Development, 1994
- Intellectual function in long-term survivors of childhood acute lymphoblastic leukemia: Protective effect of pre-irradiation methotrexate a childrens cancer study group studyMedical and Pediatric Oncology, 1991
- Neurotoxicity Due to Central Nervous System Therapy for Childhood LeukemiaJournal of Pediatric Hematology/Oncology, 1989
- Identification of Leukemic Cells in the Cerebro spinal Fluid from Children with Acute Lymphoblastic LeukemiaJournal of Pediatric Hematology/Oncology, 1989
- Acute Encephalopathy During Induction Therapy for Acute Lymphoblastic LeukemiaPediatric Hematology and Oncology, 1986